Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development

Psychopharmacology

Volumn 163, Issue 3-4, 2002, Pages 265-282

  Platt, Donna M ^a   Rowlett, James K ^a   Spealman, Roger D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Behavioral effects of cocaine; Cocaine discrimination; Cocaine relapse; Cocaine self administration; Dopamine receptor agonists, antagonists and partial agonists; Dopamine sparing cocaine antagonists; Dopamine uptake inhibitors; Medication development

Indexed keywords

2 DIPROPYLAMINO 1,2,3,4 TETRAHYDRO 6 (4 METHOXYPHENYLSULFONYLMETHYL)NAPHTHALENE; 2 DIPROPYLAMINO 5,6 DIMETHOXYINDAN; 2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 PHENYL 1H 3 BENZAZEPINE; 2BETA PROPANOYL 3BETA (4 TOLYL)TROPANE; 3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; 3 ALLYL 2,3,4,5 TETRAHYDRO 1 PHENYL 1H 3 BENZAZEPINE 7,8 DIOL; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; 3BETA (4 CHLOROPHENYL) 2BETA TROPANECARBOXYLIC ACID PHENYL ESTER; 3BETA (4 CHLOROPHENYL)TROPANE 2BETA CARBOXYLIC ACID PHENYL ESTER; 3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; 4 CHLOROBENZTROPINE; 5 METHOXY 1 METHYL 2 PROPYLAMINOTETRALIN; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; A 33659; ADROGOLIDE; APOMORPHINE; BP 897; BROMOCRIPTINE; COCAINE; CP 226269; DOPAMINE 3 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE UPTAKE INHIBITOR; ECOPIPAM; ETICLOPRIDE; FLUPENTIXOL; HALOPERIDOL; L 741626; N (2 CHLORO 6 METHYLERGOLIN 8ALPHA YL)PIVALAMIDE; N (2,6 DIMETHYLERGOLIN 8ALPHA YL)PIVALAMIDE; N [4 [2 (6 CYANO 1,2,3,4 TETRAHYDRO 2 ISOQUINOLINYL)ETHYL]CYCLOHEXYL] 4 QUINOLINECARBOXAMIDE; PD 168077; PIMOZIDE; PROPYLNORAPOMORPHINE; QUINPIROLE; S 33084; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANOXERINE;

BEHAVIOR; CLINICAL TRIAL; COCAINE DEPENDENCE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DYSKINESIA; HEADACHE; HUMAN; MAINTENANCE THERAPY; MENTAL DISEASE; MOTOR DYSFUNCTION; NAUSEA; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; REINFORCEMENT; REVIEW; VERTIGO;

ANIMALS; BEHAVIOR, ANIMAL; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE AGENTS; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DRUG EVALUATION, PRECLINICAL; SELF ADMINISTRATION;

EID: 0036392443     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1137-8     Document Type: Review

References (222)

1. Acri JB, Carter SR, Alling K, Geter-Douglass B, Dijkstra D, Wikstrom H, Katz JL, Witkin JM (1995) Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands. Eur J Pharmacol 281:R7-R9
2. Anderson KG, van Haaren F (2000) Effects of SCH-23390 and raclopride on cocaine discrimination in male and female Wistar rats. Pharmacol Biochem Behav 65:671-675
3. 3H] GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex. J Neurochem 48:1887-1896
4. Ariëns EJ (1983) Intrinsic activity: partial agonists and partial antagonists. J Cardiovasc Pharmacol 5:S8-S15
5. 1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro. Eur J Pharmacol 213:259-267
6. Baker LE, Riddle EE, Saunders RB, Appel JB (1993) The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behav Pharmacol 4:69-79
7. Baker LE, Miller ME, Svensson KA (1997) Assessment of the discriminative stimulus effects of the D3 dopamine antagonist PNU-99194A in rats: comparison with psychomotor stimulants. Behav Pharmacol 8:243-252
8. Balster RL, Schuster CR (1973) Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration. J Exp Anal Behav 20:119-129
9. Bardo MT, Bevins RA (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology 153:31-43
10. Barrett JE, Katz JL (1981) Drug effects on behaviors maintained by different events. In: Thompson T, Dews PB (eds) Advances in behavioral pharmacology, vol 3. Academic Press, San Diego, pp 119-168
11. Barrett RL, Appel JB (1989) Effects of stimulation and blockade of dopamine receptor subtypes on the discriminative stimulus properties of cocaine. Psychopharmacology 99:13-16
12. Baumann MH, Chan GU, De Costa BR, Rice KC, Rothman RB (1994) GBR 12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat. J Pharmacol Exp Ther 271:1216-1222
13. Baxter BL, Gluckman MI, Stein L, Scerni RA (1974) Self-injection of apomorphine in the rat: positive reinforcement by a dopamine receptor stimulant. Pharmacol Biochem Behav 2:387-391
14. Beardsley PM, Sokoloff P, Balster RL, Schwartz JC (2001) The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and D-amphetamine and is not self-administered. Behav Pharmacol 12:1-11
15. Bennett BA, Wichems CH, Hollingsworth CK, Davies HML, Thornley C, Sexton T, Childers SR (1995) Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain. J Pharmacol Exp Ther 272:1176-1186
16. Berger SP, Hall S, Mickalian JD, Reid Ms, Crawford CA, Delucchi K, Carr K, Hall S (1996) Haloperidol antagonism of cue-elicited cocaine craving. Lancet 347:504-508
17. Bergman J, Rosenzweig-Lipson S (1992) Cocaine-antagonist effects of limited-efficacy D1 agonists. NIDA Res Monogr 119:185-189
18. Bergman J, Madras BK, Johnson SE, Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther 251:150-155
19. 2 antagonists. Behav Pharmacol 1:355-363
20. 2 dopamine receptor antagonists in squirrel monkeys. J Pharmacol Exp Ther 258:910-917
21. 2 receptor agonists on schedule-controlled behavior of squirrel monkeys. J Pharmacol Exp Ther 273:40-48
22. Birmingham AM, Nader SH, Grant KA, Davies HML, Nader MA (1998) Further evaluation of the reinforcing effects of the novel cocaine analog 2β-propanoyl-3β-(4-tolyl)-tropane (PTT) in rhesus monkeys. Psychopharmacology 136:139-147
23. Britton DR, Curzon P, Mackenzie RG, Kebabian JW, Williams JE, Kerkman D (1991) Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration. Pharmacol Biochem Behav 39:911-915
24. Bukofzer S, Livesey N (2001) Safety and tolerability of apomorphine SL (Uprima). Int J Impot Res 13:S40-S44
25. Caine SB, Koob GF (1993) Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science 260:1814-1816
26. Caine SB, Koob GF (1994) Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther 270:209-218
27. Caine SB, Koob GF, Parsons LH, Everitt BJ, Schwartz JC, Sokoloff P (1997) D3 receptor test in vitro predicts decreased cocaine self-administration in rats. Neuroreport 8:2373-2377
28. Caine SB, Negus SS, Mello NK, Bergman J (1999) Effects of dopamine D1-like and D2-like agonists in rats that self-administer cocaine. J Pharmacol Exp Ther 291:353-360
29. Caine SB, Negus SS, Mello NK, Bergman J (2000a) Effects of dopamine D1-like and D2-like agonists in rats trained to discriminate cocaine from saline: influence of experimental history. Exp Clin Psychopharmacol 8:404-414
30. Caine SB, Negus SS, Mello NK, Bergman J (2000b) Effects of dopamine D1-like and D2-like agonists on cocaine self-administration in rhesus monkeys: rapid assessment of cocaine dose-effect functions. Psychopharmacology 148:41-51
31. Callahan PM, Cunningham KA (1993) Discriminative stimulus properties of cocaine in relation to dopamine D2 receptor function in rats. J Pharmacol Exp Ther 266:585-592
32. Callahan PM, Appel JB, Cunningham KA (1991) Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine. Psychopharmacology 103:50-55
33. 3H]cocaine in striatum and its relationship to the dopamine transporter. Membr Biochem 7:87-106
34. Carroll FI, Kotian P, Dehghani A, Gray JL, Kuzemko MA, Parham KA, Abraham P, Lewin AH, Boja JW, Kuhar MJ (1995) Cocaine and 3β-(4′-substituted phenyl)tropane-2β-carboxylic acid ester and amide analogues. New high affinity and selective compounds for the dopamine transporter. J Med Chem 38:379-388
35. Carroll FI, Howell LL, Kuhar MJ (1999) Pharmacotherapies for treatment of cocaine abuse: preclinical aspects. J Med Chem 42:2721-2736
36. Chausmer AL, Katz JL (2002) Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents. Psychopharmacology 159:145-153
37. Civelli O, Bunzow JR, Grandy DK, Zhou Q-Y, Van Tol HHM (1991) Molecular biology of the dopamine receptors. Eur J Pharmacol Mol Pharmacol Sect 207:277-286
38. Clarke RL, Daum SJ, Gambino AJ, Aceto MD, Pearl J, Levitt M, Cumisky WR, Bogado EF (1973) Compounds affecting the central nervous system. 4. 3β-phenyltropane-2-carboxylic esters and analogs. J Med Chem 16:1260-1267
39. Cline EJ, Scheffel U, Boja JW, Carroll FI, Katz JL, Kuhar MJ (1992a) Behavioral effects of novel cocaine analogs: a comparison with in vivo receptor binding potency. J Pharmacol Exp Ther 260:1174-1179
40. Cline EJ, Terry P, Carroll FI, Kuhar MJ, Katz JL (1992b) Stimulus generalization from cocaine to analogs with high in vitro affinity for dopamine uptake sites. Behav Pharmacol 3:113-116
41. 4 dopamine receptor agonists and antagonists. Neuropsychopharmacology 22:538-544
42. 1 receptors. J Pharmacol Exp Ther 249:769-774
43. Comer SD, Collins ED, Kleber HD, Nuwayser ES, Kerrigan JH, Fischman MW (2002) Depot naltrexone: long-lasting antagonism of the effects of heroin in humans. Psychopharmacology 159:351-360
44. Cook CD, Carroll FI, Beardsley PM (2001) Cocaine-like discriminative stimulus effects of novel cocaine and 3-phenyltropane analogs in the rat. Psychopharmacology 159:58-63
45. Corrigall WA, Coen KM (1991) Cocaine self-administration is increased by both D1 and D2 dopamine antagonists. Pharmacol Biochem Behav 39:799-802
46. Costanza RM, Terry P (1998) The dopamine D4 receptor antagonist L-745,870: effects in rats discriminating cocaine from saline. Eur J Pharmacol 345:129-132
47. Costanza RM, Barber DJ, Terry P (2001) Antagonism of the discriminative stimulus effects of cocaine at two training doses by dopamine D2-like receptor antagonists. Psychopharmacology 158:146-153
48. Courty E, Durif F, Zenut M, Courty P, Lavarenne J (1997) Psychiatric and sexual disorders induced by apomorphine in Parkinson's disease. Clin Neuropharmacol 20:140-147
49. Coward DM, Dixon AK, Urwyler S, White TG, Enz A, Karobath M, Shearman G (1990) Partial dopamine-agonistic and atypical neuroleptic properties of the amino-ergolines SDZ 208-911 and SDZ 208-912. J Pharmacol Exp Ther 252:279-285
50. Dackis CA, Gold MS, Sweeney DR, Byron JP, Climko R (1987) Single-dose bromocriptine reverses cocaine craving. Psychiatry Res 20:261-264
51. Depoortere R, Perrault G, Sanger DJ (1996) Behavioral effects in the rat of the putative D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine. Psychopharmacology 124:231-240
52. Deutsch HM, Shi Q, Gruszecka-Kowalik E, Schweri MM (1996) Synthesis and pharmacology of potential cocaine antagonists. 2. Structure-activity relationship studies of aromatic ring-substituted methylphenidate analogs. J Med Chem 39:1201-1209
53. Deutsch HM, Collard DM, Zhang L, Burnham KS, Deshpande AK, Holtzman SG, Schweri MM (1999) Synthesis and pharmacology of site-specific cocaine abuse treatment agents: 2-(aminomethyl)-3-phenylbicyclo[2.2.2]- and -[2.2.1]alkane dopamine uptake inhibitors. J Med Chem 42:882-895
54. De Vries TJ, Schoffelmeer AN, Binnekade R, Vanderschuren LJ (1999) Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration. Psychopharmacology 143:254-260
55. De Wit H, Stewart J (1981) Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology 75:134-143
56. Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278
57. Dworkin SI, Lambert P, Sizemore GM, Carroll FI, Kuhar MJ (1998) RTI-113 administration reduces cocaine self-administration at high occupancy of dopamine transporter. Synapse 30:49-55
58. Einsiedel J, Hubner H, Gmeiner P (2001) Benzamide bioisosteres incorporating dihydroheteroazole substructures: EPC synthesis and SAR leading to a selective dopamine D4 receptor partial agonist (FAUC 179). Bioorg Med Chem Lett 11:2533-2536
59. Ettenberg A, Pettit HO, Bloom FE, Koob GF (1982) Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology 78:204-209
60. Evans SM, Walsh SL, Levin FR, Foltin RW, Fischman MW, Bigelow GE (2001) Effect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans. Drug Alcohol Depend 64:271-283
61. Everitt BJ, Di Ciano P, Underwood R, Hagan J (2001) Attenuation of drug-seeking by a selective D3 dopamine receptor antagonist. Soc Neuro Abstr 27:647.9
62. Garner KJ, Baker LE (1999) Analysis of D2 and D3 receptor-selective ligands in rats trained to discriminate cocaine from saline. Pharmacol Biochem Behav 64:373-378
63. Gawin FH, Allen D, Humblestone B (1989) Outpatient treatment of 'crack' cocaine smoking with flupenthixol decanoate. A preliminary report. Arch Gen Psychiatry 46:322-325
64. Gawin FH, Khalsa-Denison ME, Jatlow P (1996) Flupentixol-induced aversion to crack cocaine. New Engl J Med 334:1340-1341
65. 2 receptor agonists. J Pharmacol Exp Ther 283:7-15
66. Giannini AJ, Folts DJ, Feather JN, Sullivan BS (1989) Bromocriptine and amantadine in cocaine detoxification. Psychiatry Res 29:11-16
67. Giardina WJ, Williams M (2001) Adrogolide HCl (ABT-431; DAS-431), a prodrug of the dopamine D1 receptor agonist, A-86929: preclinical pharmacology and clinical data. CNS Drug Rev 7:305-316
68. Giros B, Wang YM, Suter S, McLeskey S, Pifl C, Caron M (1994) Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J Biol Chem 23:15985-15988
69. Glowa JR (1996) Dose-response analysis in risk assessment: Evaluation of behavioral specificity. Environ Health Perspect 104:391-396
70. Glowa JR, Wojinicki FHE, Matecka D, Bacher J, Mansbach RS, Balster RL, Rice KC (1995) Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding. I. Dependence on unit dose of cocaine. Exp Clin Psychopharmacol 3:219-231
71. Gorelick DA (1998) The rate hypothesis and agonist substitution approach to cocaine abuse treatment. Adv Pharmacol 42:995-997
72. Gottschalk PC, Jacobsen LK, Kosten TR (1999) Current concepts in pharmacotherapy of substance abuse. Curr Psychiatry Rep 1:172-178
73. Grabowski J, Roache JD, Schmitz JM, Rhoades H, Creson D, Korszun A (1997) Replacement medication for cocaine dependence: methylphenidate. J Clin Psychopharmacol 17:485-488
74. Grech DM, Spealman RD, Bergman J (1996) Self-administration of D1 receptor agonists by squirrel monkeys. Psychopharmacology 125:97-104
75. Handelsman L, Rosenblum A, Palij M, Magura S, Foote J, Lovejoy M, Stimmel B (1997) Bromocriptine for cocaine dependence. A controlled clinical trial. Am J Addict 6:54-64
76. Haney M, Collins ED, Ward AS, Foltin RW, Fischman MW (1999) Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans. Psychopharmacology 143:102-110
77. Haney M, Ward AS, Foltin RW, Fischman MW (2001) Effects of ecopipam, a selective D1 antagonist, on smoked cocaine self-administration by humans. Psychopharmacology 155:330-337
78. Heikkila RE, Cabbat FS, Manzino L, Duvoisin RC (1979) Rotational behavior induced by cocaine analogs in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra: dependence upon dopamine uptake inhibition. J Pharmacol Exp Ther 211:189-194
79. Holtzman SG (2001) Differential interaction of GBR 12909, a dopamine uptake inhibitor, with cocaine and methamphetamine in rats discriminating cocaine. Psychopharmacology 155:180-186
80. Horn AS (1990) Dopamine uptake: a review of progress in the last decade. Prog Neurobiol 34:387-400
81. Howell LL, Byrd LD (1991) Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey. J Pharmacol Exp Ther 258:178-185
82. Howell LL, Wilcox KM (2001) The dopamine transporter and cocaine medication development: drug self-administration in nonhuman primates. J Pharmacol Exp Ther 298:1-6
83. Howell LL, Czoty PW, Byrd LD (1997) Pharmacological interactions between serotonin and dopamine on behavior in the squirrel monkey. Psychopharmacology 131:40-48
84. Howell LL, Czoty PW, Kuhar MJ, Carroll FI (2000) Comparative behavioral pharmacology of cocaine and the selective dopamine uptake inhibitor RTI-113 in the squirrel monkey. J Pharmacol Exp Ther 292:521-529
85. Hubner CB, Moreton JE (1991) Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology 105:151-156
86. Hurd YL, Kehr J, Ungerstedt U (1988) In vivo microdialysis as a technique to monitor drug transport: correlation of extracellular cocaine levels and dopamine overflow in the rat brain. J Neurochem 51:1314-1316
87. Jarbe TU (1984) Discriminative stimulus properties of cocaine. Effects of apomorphine, haloperidol, procaine and other drugs. Neuropharmacology 23:899-907
88. Katz JL, Witkin JM (1991) Behavioral effects of cocaine alone and in combination with selective dopamine antagonists in the squirrel monkey. Psychopharmacology 103:33-40
89. Katz JL, Witkin JM (1992a) Effects of quinpirole and SKF 38393 alone and in combination in squirrel monkeys trained to discriminate cocaine. Psychopharmacology 107:217-220
90. 1 dopamine receptor agonist, SKF 38393, on behavior maintained by cocaine injection in squirrel monkeys. Psychopharmacology 109:241-244
91. Katz JL, Kopajtic TA, Myers KA, Mitkus RJ, Chider M (1999) Behavioral effects of cocaine: Interactions with D1 dopaminergic antagonists and agonists in mice and squirrel monkeys. J Pharmacol Exp Ther 291:265-279
92. Katz JL, Izenwasser S, Terry P (2000) Relationships among dopamine transporter affinities and cocaine-like discriminative-stimulus effects. Psychopharmacology 148:90-98
93. Katz JL, Agoston GE, Alling KL, Kline RH, Forster MJ, Woolverton WL, Kopajtic TA, Newman AH (2001) Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents. Psychopharmacology 154:362-374
94. Kelleher RT (1976) Characteristics of behavior controlled by scheduled injections of drugs. Pharmacol Rev 27:307-323
95. Kelleher RT, Goldberg SR (1976) General introduction: control of drug-taking behavior by schedules of reinforcement. Pharmacol Rev 27:291-99
96. Kelleher RT, Morse WH (1968) Determinants of the specificity of behavioral effects of drugs. Ergeb Physiol 60:1-56
97. Kelley AE, Lang CG (1989) Effects of GBR 12909, a selective dopamine uptake inhibitor, on motor activity and operant behavior in the rat. Eur J Pharmacol 167:385-395
98. Khalsa ME, Jatlow P, Gawin FH (1994) Flupenthixol and desipramine treatment of crack abusers: double-blind results. NIDA Res Monogr 141:438
99. Khroyan TV, Barrett-Larimore RL, Rowlett JK, Spealman RD (2000) Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists. J Pharmacol Exp Ther 294:680-687
100. Kita K, Shiratani T, Takenouchi K, Fukuzako H, Takigawa M (1999) Effects of D1 and D2 dopamine receptor antagonists on cocaine-induced self-stimulation and locomotor activity in rats. Eur Neuropsychopharmacol 9:1-7
101. Kitayama S, Shimada S, Xu H, Markham L, Donovan DM, Uhl GR (1992) Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc Natl Acad Sci USA 89:7782-7785
102. Kleber HD (1995) Pharmacotherapy, current and potential, for the treatment of cocaine dependence. Clin Neuropharmacol 18:S96-S109
103. Kleven MS, Woolverton WL (1990a) Effects of bromocriptine and desipramine on behavior maintained by cocaine or food presentation in rhesus monkeys. Psychopharmacology 101:208-213
104. Kleven MS, Woolverton WL (1990b) Effects of continuous infusions of SCH 23390 on cocaine- or food-maintained behavior in rhesus monkeys. Behav Pharmacol 1:365-373
105. Kleven MS, Anthony EW, Woolverton WL (1990) Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 254:312-317
106. Kline RH, Izenwasser S, Katz JL, Joseph DB, Bowen WD, Newman AH (1997) 3′-chloro-3α-(diphenylmethoxy)tropane but not 4′-chloro-3α-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile. J Med Chem 40:851-857
107. Koe BK (1976) Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther 199:649-661
108. Koetzner L, Riley AL, Glowa JR (1996) Discriminative stimulus effects of dopaminergic agents in rhesus monkeys. Pharmacol Biochem Behav 54:517-523
109. Koller WC, Rueda MG (1998) Mechanism of action of dopaminergic agents in Parkinson's disease. Neurology 50:S11-S48
110. Kosten TA, Kosten TR (1991) Pharmacological blocking agents for treating substance abuse. J Nerv Ment Dis 179:583-592
111. Kosten TR, Kleber HD (1984) Strategies to improve compliance with narcotic antagonists. Am J Drug Alcohol Abuse 10:249-266
112. Kreek MJ (1992) Rationale for maintenance pharmacotherapy of opiate dependence. Res Publ Assoc Res Nerv Ment Dis 70:205-230
113. Kumor K, Sherer M, Jaffe J (1989) Effects of bromocriptine pretreatment on subjective and physiological responses to i.v. cocaine. Pharmacol Biochem Behav 33:829-837
114. 4, receptors in the striatum without the involvement of action potentials. J Neurosci 20:6666-6671
115. Lamas X, Negus SS, Nader MA, Mello NK (1996) Effects of the putative dopamine D3 receptor agonist 7-OH-DPAT in rhesus monkeys trained to discriminate cocaine from saline. Psychopharmacology 124:306-314
116. Langston JW, Ballard P (1984) Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson's disease. Can J Neurol Sci 11:160-165
117. Lile JA, Morgan D, Nader MA (2000a) First- versus last-session substitution: an evaluation of the reinforcing effects of cocaine and the cocaine analogue 2β-propanoyl-3β-(4-tolyl)-tropane. Exp Clin Psychopharmacol 8:424-433
118. Lile JA, Morgan D, Freedland CS, Sinnott RS, Davies HML, Nader MA (2000b) Self-administration of two long-acting monoamine transport blockers in rhesus monkeys. Psychopharmacology 152:414-421
119. Ling W, Wesson DR (1984) Naltrexone treatment for addicted health-care professionals: a collaborative private practice experience. J Clin Psychiatry 45:46-48
120. 3H] Cocaine binding sites in caudate-putamen. J Pharmacol Exp Ther 251:131-141
121. Madras BK, Kamien JB, Fahey MA, Canfield DR, Milius RA, Saha JK, Neumeyer JL, Spealman RD (1990) N-modified fluorophenyltropane analogs of cocaine with high affinity for cocaine receptors. Pharmacol Biochem Behav 35:949-953
122. Malcolm R, Kajdasz DK, Herron J, Anton RF, Brady KT (2000) A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence. Drug Alcohol Depend 60:161-168
123. Malcolm R, Herron J, Sutherland SE, Brady KT (2001) Adverse outcomes in a controlled trial of pergolide for cocaine dependence. J Addict Dis 20:81-92
124. Manzardo AM, Del Rio JA, Stein L, Belluzzi JD (2001) Rats choose cocaine over dopamine agonists in a two-lever self-administration preference test. Pharmacol Biochem Behav 70:257-265
125. McCance-Katz EF, Kosten TA, Kosten TR (2001) Going from the bedside back to the bench with ecopipam: a new strategy for cocaine pharmacotherapy development. Psychopharmacology 155:327-329
126. McKearney JW (1974) Effects of d-amphetamine, morphine and chlorpromazine on responding under fixed-interval schedules of food presentation or electric shock presentation. J Pharmacol Exp Ther 190:141-153
127. Melia KF, Spealman RD (1991) Pharmacological characterization of the discriminative-stimulus effects of GBR 12909. J Pharmacol Exp Ther 258:626-632
128. Mello NK, Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375-424
129. Mendelson JH, Mello NK (1996) Management of cocaine abuse and dependence. N Engl J Med 334:965-972
130. 3-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626. J Pharmacol Exp Ther 293:1063-1073
131. Morse WH, Kelleher RT (1970) Schedules as fundamental determinants of behavior. In: Schoenfeld WN (ed) The theory of reinforcement schedules. Appleton-Century-Crofts, New York, pp 139-185
132. Morse WH, McKearney JW, Kelleher RT (1977) Control of behavior by noxious stimuli. In: Iverson LL, Iverson SD, Snyder SH (eds) Handbook of psychopharmacology, vol 7. Plenum Press, New York, pp 151-180
133. Nader MA, Mach RH (1996) Self-administration of the dopamine D3 agonist 7-OH-DPAT in rhesus monkeys is modified by prior cocaine exposure. Psychopharmacology 125:13-22
134. Nader MA, Grant KA, Davies HML, Mach RH, Childers SR (1997) The reinforcing and discriminative stimulus effects of the novel cocaine analog 2β-propanoyl-3β-(4-tolyl)-tropane in rhesus monkeys. J Pharmacol Exp Ther 280:541-550
135. Nader MA, Green KL, Luedtke RR, Mach RH (1999) The effects of benzamide analogues on cocaine self-administration in rhesus monkeys. Psychopharmacology 147:143-152
136. 1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine. Psychopharmacology 155:338-347
137. Negus SS, Mello NK, Lamas X, Mendelson JH (1996) Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 278:879-890
138. Newman AH, Allen AC, Izenwasser S, Katz JL (1994) Novel 3α-(diphenylmethoxy)tropane analogs: potent dopamine uptake inhibitors without cocaine-like behavioral profiles. J Med Chem 37:2258-2261
139. Ohuoha DC, Maxwell JA, Thomson LE, Cadet JL, Rothman RB (1997) Effect of dopamine receptor antagonists on cocaine subjective effects: a naturalistic case study. J Subst Abuse Treat 14:249-258
140. Oliveto A, McCance-Katz FE, Singha A, Petrakis I, Hameedi F, Kosten TR (2001) Effects of cocaine prior to and during buproprion maintenance in cocaine-abusing volunteers. Drug Alcohol Depend 63:155-167
141. 3 receptor agonists reduces spontaneous and dopamine-induced locomotion. Pharmacol Biochem Behav 67:637-645
142. Panlilio LV, Goldberg SR, Gilman JP, Jufer R, Cone EJ, Schindler CW (1998) Effects of delivery rate and non-contingent infusions of cocaine on cocaine self-administration in rhesus monkeys. Psychopharmacology 137:253-258
143. Pellon R, Flores P, Alling K, Witkin JM, Katz JL (1995) Pharmacological analysis of the scratching produced by dopamine D2 agonists in squirrel monkeys. J Pharmacol Exp Ther 273:138-145
144. Pettit HO, Justice JB (1989) Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis. Pharmacol Biochem Behav 34:899-904
145. 3 receptor agonist. Nature 400:371-375
146. Pilla M, Hutcheson DM, Adib-Samil P, Potton E, Everitt BJ (2001) Seeking responses for cocaine, heroin and natural reinforcers are differentially modulated by dopamine D3 receptors. Soc Neuro Abstr 27:647.16
147. Platt DM, Rowlett JK, Spealman RD (2000) Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434. J Pharmacol Exp Ther 293:1017-1026
148. Platt DM, Rowlett JK, Spealman RD (2001a) Modulation of cocaine and food self-administration by low- and high-efficacy D1 agonists in squirrel monkeys. Psychopharmacology 157:208-216
149. Platt DM, Rowlett JK, Spealman RD (2001b) Monoaminergic transport mechanisms in relapse to cocaine-seeking behavior. Soc Neuro Abstr 27:788.2
150. Preti A (2000a) BP-897 bioprojet. Curr Opin Invest Drugs 1:110-115
151. Preti A (2000b) Vanoxerine National Institute on Drug Abuse. Curr Opin Invest Drugs 1:241-251
152. Pulvirenti L, Smith D, Koob GF (1994) SDZ 208-911, an amino-ergoline with partial dopamine agonist properties, dose dependently increases cocaine self-administration in the rat. Psychopharmacology 113:518-520
153. Pulvirenti L, Balducci C, Piercy M, Koob GF (1998) Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat. J Pharmacol Exp Ther 286:1231-1238
154. Ranaldi R, Wang Z, Woolverton WL (2001) Reinforcing effects of D2 dopamine receptor agonists and partial agonists in rhesus monkeys. Drug Alcohol Depend 64:209-217
155. Reith ME, Salmeci G (1992) Radiolabeling of dopamine uptake sites in mouse striatum: comparison of binding sites for cocaine, mazindol, and GBR 12935. Naunyn-Schmiedeberg's Arch Pharmacol 345:309-318
156. Richardson NR, Smith AM, Roberts DC (1994) A single injection of either flupenthixol decanoate or haloperidol decanoate produces long-term changes in cocaine self-administration in rats. Drug Alcohol Depend 36:23-25
157. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219-1223
158. Roberts DCS (1993) Self-administration of GBR 12909 on a fixed ratio and progressive ratio schedule in rats. Psychopharmacology 111:202-206
159. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18:247-291
160. 5 antagonist ecopipam. Arch Gen Psychiatry 56:1101-1106
161. 1 receptor agonists in squirrel monkeys. Eur J Pharmacol 260:237-241
162. Rosenzweig-Lipson S, Bergman J, Spealman RD, Madras BK (1992) Stereoselective behavioral effects of Lu 19-005 in monkeys: relation to binding at cocaine recognition sites. Psychopharmacology 107:186-194
163. 2 agonists in squirrel monkeys. Psychopharmacology 116:9-18
164. 3H]DA-uptake-inhibition to transporter-binding-inhibition ratios for the in vitro evaluation of putative cocaine antagonists. Life Sci 53:PL267-PL272
165. Schwartz JC, Giros B, Martres MP, Sokoloff P (1992) The dopamine receptor family: molecular biology and pharmacology. Neurosciences 4:99-108
166. Self DW, Stein L (1992) The D1 agonists SKF 82958 and SKF 77434 are self-administered in rats. Brain Res 582:349-352
167. Self DW, Barnhart WJ, Lehman DA, Nestler EJ (1996) Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science 271:1586-1589
168. Self DW, Karanian DA, Spencer JJ (2000) Effects of the novel D1 dopamine receptor agonist ABT-431 on cocaine self-administration and reinstatement. Ann NY Acad Sci 909:133-144
169. Shalev U, Grimm JW, Shaham Y (2002) Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54:1-42
170. Sherer MA, Kumor KM, Jaffe JH (1989) Effects of intravenous cocaine are partially attenuated by haloperidol. Psychiatry Res 27:117-125
171. Shiosaki K, Asin KE, Britton DR, Giardina WJ, Bednarz L, Mahan L,
172. Sibley DR, Monsma FJ (1992) Molecular biology of dopamine receptors. Trends Pharmacol Sci 13:61-69
173. Sinnott RS, Mach RH, Nader MA (1999) Dopamine D2/D3 receptors modulate cocaine's reinforcing and discriminative stimulus effects in rhesus monkeys. Drug Alcohol Depend 54:97-110
174. Slusher BS, Tiffany CW, Olkowski JL, Jackson PF (1997) Use of identical assay conditions for cocaine analog binding and dopamine uptake to identify potential cocaine antagonists. Drug Alcohol Depend 48:43-50
175. Sogaard U, Michalow J, Butler B, Lund Laursen A, Ingersen SH, Skrumsager BK, Rafaelsen OJ (1990) A tolerance study of single and multiple dosing of the selective dopamine uptake inhibitor GBR 12909 in healthy subjects. Int Clin Psychopharmacol 5:237-251
176. Spealman RD (1979) Behavior maintained by termination of a schedule of self-administered cocaine. Science 204:1231-33
177. Spealman RD (1990) Antagonism of behavioral effects of cocaine by selective dopamine receptor blockers. Psychopharmacology 101:142-145
178. Spealman RD (1992) Use of cocaine-discrimination techniques for preclinical evaluation of candidate therapeutics for cocaine dependence. NIDA Res Monogr 119:175-179
179. Spealman RD (1993) Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys. Psychopharmacology 112:93-99
180. 2 partial agonists terguride, SDZ 208-911, and SDZ 208-912. Pharmacol Biochem Behav 51:661-665
181. Spealman RD (1996) Dopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 278:1128-1137
182. Spealman RD, Kelleher RT (1981) Self-administration of cocaine derivatives by squirrel monkeys. J Pharmacol Exp Ther 216:532-536
183. Spealman RD, Goldberg SR, Kelleher RT, Goldberg DM, Charlton JP (1977) Some effects of cocaine and two cocaine analogs on schedule-controlled behavior of squirrel monkeys. J Pharmacol Exp Ther 202:500-509
184. Spealman RD, Goldberg SR, Kelleher RT, Morse WH, Goldberg DM, Hakansson CG, Nieforth KA, Lazer ES (1979) Effects of norcocaine and some norcocaine derivatives on schedule-controlled behavior of pigeons and squirrel monkeys. J Pharmacol Exp Ther 210:196-205
185. Spealman RD, Madras BK, Bergman J (1989) Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior. J Pharmacol Exp Ther 251:142-149
186. Spealman RD, Bergman J, Madras BK (1991a) Self-administration of the high-affinity cocaine analog 2β-carbomethoxy-3β-(4-fluorophenyl)tropane. Pharmacol Biochem Behav 39:1011-1013
187. Spealman RD, Bergman J, Madras BK, Melia KF (1991b) Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes. J Pharmacol Exp Ther 258:945-953
188. 2 dopamine receptors in the behavioral effects of cocaine. Neurochem Int 20:147S-152S
189. 1 agonists. Psychopharmacology 133:283-292
190. Spealman RD, Barrett-Larimore RL, Rowlett JK, Platt DM, Khroyan TV (1999) Pharmacological and environmental determinants of relapse to cocaine-seeking behavior. Pharmacol Biochem Behav 64:327-336
191. Stafford D, LeSage MG, Rice KC, Glowa JR (2001) A comparison of cocaine, GBR 12909, and phentermine self-administration by rhesus monkeys on a progressive-ratio schedule. Drug Alcohol Depend 62:41-47
192. 1 agonists does not correlate with other dopaminergic properties. J Neural Transm 6:27-34
193. Stewart J (2000) Pathways to relapse: the neurobiology of drug-and stress-induced relapse to drug-taking. J Psychiatry Neurosci 25:125-136
194. Stine SM, Krystal JH, Kosten TR, Charney DS (1995) Mazindol treatment for cocaine dependence. Drug Alcohol Depend 39:245-252
195. Stitzer ML, Walsh SL (1997) Psychostimulant abuse: the case for combined behavioral and pharmacological treatments. Pharmacol Biochem Behav 57:457-470
196. Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies (2000) Summary of findings from the 1999 national household survey on drug abuse (NHSDA). U.S. Department of Health and Human Services, Rockville, Maryland
197. Tella SR (1995) Effects of monoamine reuptake inhibitors on cocaine self-administration in rats. Pharmacol Biochem Behav 51:687-692
198. Tella SR, Ladenheim B, Andrews AM, Goldberg SR, Cadet JL (1996) Differential reinforcing effects of cocaine and GBR-12909: biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system. J Neurosci 16:7416-7427
199. Tidey JW, Bergman J (1998) Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs. J Pharmacol Exp Ther 285:1163-1174
200. Tolliver BK, Newman AH, Katz JL, Ho LB, Fox LM, Hsu K, Berger SP (1999) Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo. J Pharmacol Exp Ther 289:110-122
201. Uhl GR, Lin Z, Metzger T, Dar DE (1998) Dopamine transporter mutations, small molecules, and approaches to cocaine antagonist/dopamine transporter disinhibitor development. Methods Enzymol 296:456-465
202. Ukai M, Mori E, Kameyama T (1993) Discriminative stimulus properties of cocaine in the rat using a two-choice discrete-trial avoidance paradigm. Pharmacol Biochem Behav 44:907-911
203. 1 dopamine antagonists SCH-39166 and A-66359. Behav Pharmacol 2:151-159
204. Vanover KE, Piercey MF, Woolverton WL (1993) Evaluation of the reinforcing and discriminative stimulus effects of cocaine in combination with (+)-AJ 76 or clozapine. J Pharmacol Exp Ther 266:780-789
205. Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, Vitkun S, Logan J, Gatley SJ, Pappas N, Hitzemann R, Shea CE (1997) Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 386:827-830
206. Weed MR, Woolverton WL (1995) The reinforcing effects of dopamine D1 receptor agonists in rhesus monkeys. J Pharmacol Exp Ther 275:1367-1374
207. 1 dopamine agonist SKF 81297 in rhesus monkeys. Psychopharmacology 113:51-52
208. Weed MR, Mackevicius AS, Kebabian J, Woolverton WL (1995) Reinforcing and discriminative stimulus effects of β-CIT in rhesus monkeys. Pharmacol Biochem Behav 51:953-956
209. Weed MR, Paul IA, Dwoskin LP, Moore SE, Woolverton WL (1997) The relationship between reinforcing effects and in vitro effects of D1 agonists in monkeys. J Pharmacol Exp Ther 283:29-38
210. Weissenborn R, Deroche V, Koob GF, Weiss F (1996) Effects of dopamine agonists and antagonists on cocaine-induced operant responding for a cocaine-associated stimulus. Psychopharmacology 126:311-322
211. Wilcox KM, Rowlett JK, Paul IA, Ordway GA, Woolverton WL (2000) On the relationship between the dopamine transporter and the reinforcing effects of local anesthetics in rhesus monkeys: practical and theoretical concerns. Psychopharmacology 153:139-147
212. Winger G (1994) Dopamine antagonist effects on behavior maintained by cocaine and alfentanil in rhesus monkeys. Behav Pharmacol 5:141-152
213. Wise RA (1996) Addictive drugs and brain stimulation reward. Ann Rev Neurosci 19:319-340
214. Witkin JM, Nichols DE, Terry P, Katz JL (1991a) Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J Pharmacol Exp Ther 257:706-713
215. Witkin JM, Schindler CW, Tella SR, Goldberg SR (1991b) Interaction of haloperidol and SCH 23390 with cocaine and dopamine receptor subtype-selective agonists on schedule-controlled behavior in squirrel monkeys. Psychopharmacology 104:425-431
216. Wojnicki FH, Glowa JR (1996) Effects of drug history on the acquisition of responding maintained by GBR 12909 in rhesus monkeys. Psychopharmacology 123:34-41
217. 2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys. Pharmacol Biochem Behav 24:531-535
218. Woolverton WL, Johnson KM (1992) Neurobiology of cocaine abuse. Trends Pharmacol Sci 13:193-200
219. 2 dopamine antagonist on behavior maintained by cocaine or food. Pharmacol Biochem Behav 32:691-697
220. Woolverton WL, Goldberg LI, Ginos JZ (1984) Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J Pharmacol Exp Ther 230:678-683
221. Woolverton WL, Rowlett JK, Wilcox KM, Paul IA, Kline RH, Newman AH, Katz JL (2000) 3′- and 4′-chloro-substituted analogs of benztropine: intravenous self-administration and in vitro radioligand binding studies in rhesus monkeys. Psychopharmacology 147:426-435
222. Woolverton WL, Hecht GS, Agoston GE, Katz JL, Newman AH (2001) Further studies of the reinforcing effects of benztropine analogs in rhesus monkeys. Psychopharmacology 154:375-382